Physician profile
Gerald Bertiger
NPI 1265470140
$2,812.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,673 · 2020: $140.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,896.96 | 2019-2022 | |
| Abbvie INC. | $243.80 | 2019-2020 | |
| Gilead Sciences, INC. | $152.09 | 2019 | |
| Janssen Biotech, INC. | $118.15 | 2019 | |
| Shionogi INC | $70.55 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.01 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $48.62 | 2019-2020 | |
| Biofire Diagnostics, LLC | $33.19 | 2019 | |
| Braintree Laboratories, INC. | $31.34 | 2019 | |
| Pfizer INC. | $30.02 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $25.60 | 2019-2020 | |
| Ucb, INC. | $21.88 | 2019 | |
| Daiichi Sankyo INC. | $19.89 | 2019 | |
| Genzyme Corporation | $18.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.26 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.04 | 2019 | |
| Allergan, INC. | $15.64 | 2019 |
Research and ownership
$40,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Bertiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.